AFWM
RIGL icon

Abich Financial Wealth Management’s Rigel Pharmaceuticals RIGL Stock Holding History

Abich Financial Wealth Management’s Portfolio RIGL Stock Details RIGL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-24
Closed -$197 – 746
2024
Q2 		$197 Buy
+24
New +$251 ﹤0.01% 753

Other funds holding RIGL

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
SCM
Soleus Capital Management Greenwich, Connecticut $2.47B AUM 115.63% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Abich Financial Wealth Management's RIGL Position: Q3 2024 in Review

Abich Financial Wealth Management sold out of Rigel Pharmaceuticals (RIGL) in Q3 2024, closing a stake of 24 shares — an estimated $197 sold.

Abich Financial Wealth Management first reported a position in RIGL in Q2 2024 and held it in 1 quarter. The position peaked at $197 in Q2 2024. 93 funds tracked by Wall St. Rank hold RIGL as of Q3 2024.

  • Abich Financial Wealth Management reported no remaining Rigel Pharmaceuticals position as of Q3 2024 after selling out during the quarter.
  • Abich Financial Wealth Management sold 24 Rigel Pharmaceuticals shares in Q3 2024, an estimated $197.
  • Abich Financial Wealth Management first reported a position in Rigel Pharmaceuticals in Q2 2024 and held it in 1 quarter.
  • Abich Financial Wealth Management's Rigel Pharmaceuticals position peaked at $197 in Q2 2024.
  • 93 funds tracked by Wall St. Rank held Rigel Pharmaceuticals as of Q3 2024.

Based on Abich Financial Wealth Management's 13F filing for Q3 2024, filed 25 Oct 2024.